Detection of sputum cofilin-1 as indicator of malignancy

Cofilin-1 (CFL1), a small protein of 18 kDa, has been studied as a biomarker due to its involvement in tumor cell migration and invasion. Our aim was to evaluate CFL1 as an indicator of malignancy and aggressiveness in sputum samples. CFL1 was analyzed by ELISA immunoassay in the sputum of 73 lung cancer patients, 13 cancer-free patients, and 6 healthy volunteers. Statistical analyses included ANOVA, ROC curves, Spearman correlation, and logistic regression. Sputum CFL1 levels were increased in cancer patients compared to cancer-free patients and volunteers (P<0.05). High expression of sputum CFL1 was correlated to T4 stage (P=0.01) and N stage (P=0.03), tobacco history (P=0.01), and squamous cell carcinoma histologic type (P=0.04). The accuracy of sputum CFL1 in discriminating cancer patients from cancer-free patients and healthy volunteers were 0.78 and 0.69, respectively. CFL1 at a cut-off value of 415.25 pg/mL showed sensitivity/specificity of 0.80/0.70 in differentiating between healthy volunteers and cancer patients. Sputum CFL1 was also able to identify cancer-free patients from patients with lung cancer. The AUC was 0.70 and, at a cut-off point ≥662.63 pg/mL, we obtained 60% sensitivity and 54% specificity. Logistic regression analysis controlled for tobacco history, histologic types, and N stage showed that cancer cell-associated CFL1 was an independent predictor of death. Smoker patients with squamous cell carcinoma, lymph node metastasis and sputum CFL1>1.475 pg/mL showed augmented chance of death, suggesting lung cancer aggressiveness. CFL1 presented diagnostic value in detecting lung cancer and was associated to tumor aggressiveness.

Palavras-chave

Lung cancer, Cofilin-1, Sputum, Liquid-biopsy, Metastases, Biomarker

URI

https://observatorio.fm.usp.br/handle/OPI/26785

Referências

Aberle DR, 2013, J CLIN ONCOL, V31, P1002, DOI 10.1200/JCO.2012.43.3110
Arber S, 1998, NATURE, V393, P805
FONTANA RS, 1991, CANCER-AM CANCER SOC, V67, P1155, DOI 10.1002/1097-0142(19910215)67:4+<1155::AID-CNCR2820671509>3.0.CO;2-0
Gadgeel SM, 2016, ADV EXP MED BIOL, V890, P203, DOI 10.1007/978-3-319-24932-2_11
Hotulainen P, 2005, MOL BIOL CELL, V16, P649, DOI 10.1091/mbc.E04-07-0555
Howington JA, 2013, CHEST, V143, pE278, DOI 10.1378/chest.12-2359
Kelloff GJ, 2012, NAT REV DRUG DISCOV, V11, P201, DOI 10.1038/nrd3651
Ma H, 2013, STAT MED, V32, P3449, DOI 10.1002/sim.5777
Melamed MR, 2000, CANCER, V89, P2356, DOI 10.1002/1097-0142(20001201)89:11+<2356::AID-CNCR8>3.0.CO;2-Z
Melo SA, 2015, NATURE, V523, P177, DOI 10.1038/nature14581
Ono S, 2007, INT REV CYTOL, V258, P1, DOI 10.1016/S0074-7696(07)58001-0
Rangel M.P., 2015, Braz J Med Biol Res, V48, P557, DOI 10.1590/1414-431X20144300
TOCKMAN MS, 1986, CHEST, V89, pS324, DOI 10.1378/chest.89.4_Supplement.324S-a
Wang W, 2006, J CELL BIOL, V173, P395, DOI 10.1083/jcb.200510115
Wang WG, 2007, NAT REV CANCER, V7, P429, DOI 10.1038/nrc2148
Wistuba II, 2002, ONCOGENE, V21, P7298, DOI 10.1038/sj.onc.1205806
Yan B, 2010, ACTA HISTOCHEM, V112, P101, DOI 10.1016/j.acthis.2008.07.007
[郑育举 Zheng Yuju], 2013, [南方医科大学学报, Journal of Southern Medical University], V33, P1551
Zhu BB, 2006, CANCER RES, V66, P8640, DOI 10.1158/0008-5472.CAN-06-1443

Coleções

Artigos e Materiais de Revistas Científicas - FM/MPT
Artigos e Materiais de Revistas Científicas - HC/ICHC
Artigos e Materiais de Revistas Científicas - HC/InCor
Artigos e Materiais de Revistas Científicas - IMT
Artigos e Materiais de Revistas Científicas - LIM/03
Artigos e Materiais de Revistas Científicas - LIM/09

Carregar mais

Página do item completo